Cite
HARVARD Citation
Yang, W. et al. (2018). Dapagliflozin as add‐on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial1. Journal of diabetes. 10 (7), pp. 589-599. [Online].